Concepedia

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

Hielke J. Meulenbeld, Erik van Werkhoven, J.L. Coenen, G.J. Creemers, O. J. L. Loosveld, P.C. de Jong, Albert J. ten Tije, Sophie D. Fosså, M. Polée, Winald R. Gerritsen,

European Journal of Cancer · 2012 · 35 citations · 21 references

Concepts

MedicineOncologyUrologyChemotherapyMetastasisUrologic OncologyGenitourinary Cancer PharmacotherapyMetastatic Cancer ManagementMetastatic Disease TreatmentProstate CancerAdvanced Prostate Cancer TherapyCastration-resistant Prostate Cancer TherapyChemotherapy For Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone-sensitive Prostate Cancer TherapyProstate Cancer Hormonal TherapyProstate Cancer Hormone Therapy

References

21

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

The McGill Pain Questionnaire: Major properties and scoring methods

Ronald Melzack · Pain · 1975 · 6.9K citations

Nursing, Psychology, Pain Management +15

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine · 2004 · 5.7K citations

Medicine, Oncology, Urology +12

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

Public Health, Biostatistics, Experimental Design +10